Correlation Between Barinthus Biotherapeutics and Parker Hannifin
Can any of the company-specific risk be diversified away by investing in both Barinthus Biotherapeutics and Parker Hannifin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Barinthus Biotherapeutics and Parker Hannifin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Barinthus Biotherapeutics plc and Parker Hannifin, you can compare the effects of market volatilities on Barinthus Biotherapeutics and Parker Hannifin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Barinthus Biotherapeutics with a short position of Parker Hannifin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Barinthus Biotherapeutics and Parker Hannifin.
Diversification Opportunities for Barinthus Biotherapeutics and Parker Hannifin
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Barinthus and Parker is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Barinthus Biotherapeutics plc and Parker Hannifin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Parker Hannifin and Barinthus Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Barinthus Biotherapeutics plc are associated (or correlated) with Parker Hannifin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Parker Hannifin has no effect on the direction of Barinthus Biotherapeutics i.e., Barinthus Biotherapeutics and Parker Hannifin go up and down completely randomly.
Pair Corralation between Barinthus Biotherapeutics and Parker Hannifin
Given the investment horizon of 90 days Barinthus Biotherapeutics plc is expected to under-perform the Parker Hannifin. In addition to that, Barinthus Biotherapeutics is 10.79 times more volatile than Parker Hannifin. It trades about -0.22 of its total potential returns per unit of risk. Parker Hannifin is currently generating about -0.13 per unit of volatility. If you would invest 69,932 in Parker Hannifin on September 13, 2024 and sell it today you would lose (1,675) from holding Parker Hannifin or give up 2.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Barinthus Biotherapeutics plc vs. Parker Hannifin
Performance |
| Timeline |
| Barinthus Biotherapeutics |
| Parker Hannifin |
Barinthus Biotherapeutics and Parker Hannifin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Barinthus Biotherapeutics and Parker Hannifin
The main advantage of trading using opposite Barinthus Biotherapeutics and Parker Hannifin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Barinthus Biotherapeutics position performs unexpectedly, Parker Hannifin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Parker Hannifin will offset losses from the drop in Parker Hannifin's long position.| Barinthus Biotherapeutics vs. Mesa Air Group | Barinthus Biotherapeutics vs. Tesla Inc | Barinthus Biotherapeutics vs. Westinghouse Air Brake | Barinthus Biotherapeutics vs. BCE Inc |
| Parker Hannifin vs. Hurco Companies | Parker Hannifin vs. Enerpac Tool Group | Parker Hannifin vs. China Yuchai International | Parker Hannifin vs. Luxfer Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |